Sun Pharma's Bold $11.75 Billion Acquisition of Organon Signals Major Expansion
Sun Pharma's Strategic Move In a landmark deal, Sun Pharmaceutical Industries Ltd., India's largest pharmaceutical company, has announced its decision to acquire U.S.-based Organon for an impressive $
This acquisition signals a significant expansion of Sun Pharma's capabilities and market reach, potentially reshaping the competitive landscape in the pharmaceutical industry.
